Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children

Pediatrics International

Volumn 54, Issue 6, 2012, Pages 858-862

  Kizilca, Ozgur ^a   Siraneci, Rengin ^a   Yilmaz, Alev ^a,b   Hatipoglu, Nevin ^a   Ozturk, Erkut ^a   Kiyak, Aysel ^a   Ozkok, Dilek ^a  

^a Bakirkoy Maternity and Children's Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antimicrobial resistance; Extended spectrum beta lactamase producing bacteria; Risk factors; Urinary tract infection

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; NITROFURANTOIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; CATHETERIZATION; CHILD; COMMUNITY ACQUIRED URINARY TRACT INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING BACTERIA; FEMALE; HOSPITALIZATION; HUMAN; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RISK FACTOR; URINARY TRACT INFECTION;

BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; KLEBSIELLA; KLEBSIELLA INFECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TURKEY; URINARY TRACT INFECTIONS;

EID: 84872795818     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2012.03709.x     Document Type: Article

References (16)

1. Bensman A, Dunand O, Ulinski T. Urinary tract infection. In: Avner ED, Harmon WEB, Niaudet P, Yoshikawa N (eds). Pediatric Nephrology, 6th edn. Springer-Verlag, Berlin Heidelberg, 2009; 1299-310.
2. Günseren F, Mamikoǧlu L, Oztürk S et al. A surveillance study of antimicrobial resistance of gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. J. Antimicrob. Chemother. 1999; 43: 373-8.
3. Kuster SP, Hasse B, Huebner V et al. Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 2010; 38: 33-40.
4. Topaloglu R, Er I, Dogan BG et al. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr. Nephrol. 2010; 25: 919-25.
5. Ozçakar ZB, Yalçinkaya F, Kavaz A et al. Urinary tract infections owing to ESBL-producing bacteria: Microorganisms change - clinical pattern does not. Acta Paediatr. 2011; 100: 61-4.
6. Azap OK, Arslan H, Serefhanoǧlu K et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin. Microbiol. Infect. 2010; 16: 147-51.
7. Calbo E, Romaní V, Xercavins M et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 2006; 57: 780-83.
8. Colodner R, Rock W, Chazan B et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 2004; 23: 163-7.
9. Lee DS, Lee CB, Lee SJ. Prevalence and risk factors for extended spectrum beta-lactamase-producing uropathogens in patients with urinary tract infection. Korean J. Urol. 2010; 51: 492-7.
10. Rodríguez-Baño J, Alcalá JC, Cisneros JM et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch. Intern. Med. 2008; 168: 1897-902.
11. Dart Yin Sihoe J, Wong SN, Yeung CK. Voiding disorders. In: Geary DF, Schaefer F (eds). Comprehensive Pediatric Nephrology. Mosby, Philadelphia, PA, 2008; 587-606.
12. Pesce MA. Reference ranges for laboratory tests and procedures. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds). Nelson Textbook of Pediatrics, 18th edn. Saunders, Philadelphia, PA, 2007; 2943-54.
13. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: 13th Informational Supplement NCCLS Document M100-S13. National Committee for Clinical Laboratory Standards, Wayne, PA, 2003.
14. Bours PH, Polak R, Hoepelman AI, Delgado E, Jarquin A, Matute AJ. Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines. Int. J. Infect. Dis. 2010; 14: e770-4.
15. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann. Clin. Microbiol. Antimicrob. 2007; 23: 4-10.
16. Durmaz R, Durmaz B, Koroglu M, Tekerekoglu MS. Detection and typing of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey. Microb. Drug Resist. 2001; 7: 171-5.